Number needed to harm in the postmarketing safety evaluation: results for rosiglitazone and pioglitazone

http://www.medworm.com/index.php?rid=136687222&cid=c_64_13_f&fid=33614&url=http%3A%2F%2Fonlinelibrary.wiley.com%2Fresolve%2Fdoi%3FDOI%3D10.1002%252Fpds.3874

Comments are closed.